Co-expression of epithelial proteins, such as E-cadherin, and mesenchymal markers, such as vimentin, has been observed in the majority of circulating tumor cells (CTC) of metastatic prostate and breast cancer patients [95]. The gene discussed is CDH1; the disease is breast cancer.